These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10938961)

  • 41. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
    Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transfusion-transmitted infections: existing and emerging pathogens.
    Kaur P; Basu S
    J Postgrad Med; 2005; 51(2):146-51. PubMed ID: 16006714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Transfusion medicine--Scandinavian recommendations].
    Jørgensen J; Jensson O; Eklund J; Kornstad L; Messeter L
    Nord Med; 1994; 109(2):61-3. PubMed ID: 8121792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Transfusions of blood and blood products and virus infections].
    Wróblewska M; Piotrowska E; ĺuczak M
    Postepy Hig Med Dosw; 2002; 56(2):221-40. PubMed ID: 12107964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infectious hazards associated with blood transfusion.
    Hurley DR
    Adverse Drug React Toxicol Rev; 1995; 14(3):157-74. PubMed ID: 7492702
    [No Abstract]   [Full Text] [Related]  

  • 50. [Severe complications, adverse effects due to blood transfusion and its measures--transfusion transmitted viral infections].
    Inaba S
    Nihon Rinsho; 1997 Sep; 55(9):2320-6. PubMed ID: 9301297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improving the safety of transfusion therapy.
    Polesky HF
    Clin Lab Med; 1996 Dec; 16(4):975-88. PubMed ID: 8974206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virus safety of human blood, plasma, and derived products.
    Guertler L
    Thromb Res; 2002 Oct; 107 Suppl 1():S39-45. PubMed ID: 12379292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging infectious diseases that threaten the blood supply.
    Alter HJ; Stramer SL; Dodd RY
    Semin Hematol; 2007 Jan; 44(1):32-41. PubMed ID: 17198845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Transfusion safety and hemosurveillance].
    Romeiras MC
    Acta Med Port; 2000; 13(4):199-202. PubMed ID: 11155487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [New viral risks in blood transfusion by 2016].
    Pozzetto B; Garraud O
    Transfus Clin Biol; 2016 Feb; 23(1):20-7. PubMed ID: 26781857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Transfusion and transmission of infectious and parasitic diseases excluding AIDS and viral hepatitis].
    Ducos J
    Rev Prat; 1989 Sep; 39(20):1782-7. PubMed ID: 2554483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood safety in the Americas.
    Epidemiol Bull; 1999 Jun; 20(2):8-9. PubMed ID: 10478503
    [No Abstract]   [Full Text] [Related]  

  • 58. Virus: a concern in transfusion therapy.
    Weir JA
    NITA; 1986; 9(3):234-6. PubMed ID: 3636640
    [No Abstract]   [Full Text] [Related]  

  • 59. [Quarantine and plasmapheresis].
    Ortiz Pareja M; Terol Fernández E; Hernández Lamas MC; Sánchez Gordo F
    Sangre (Barc); 1998 Jun; 43(3):261-2. PubMed ID: 9741240
    [No Abstract]   [Full Text] [Related]  

  • 60. Blood transfusion.
    Mollison PL; Engelfriet P
    Semin Hematol; 1999 Oct; 36(4 Suppl 7):48-58. PubMed ID: 10595754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.